XML 67 R55.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value Measurements Level 3 Rollforward (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 9 Months Ended
Oct. 03, 2016
Mar. 31, 2017
Dec. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Fair Value Assumptions, Expected Term       2 months 24 days  
Fair Value Inputs, Discount Rate       1.00%  
Accelerated Share Repurchases, Cash or Stock Settlement   160      
Contingent Consideration [Roll Forward]          
Balance at June 30, 2015     $ 5.2 $ 5.2  
Additions of contingent consideration due to Health Advances acquisition $ 11.5        
Change in fair value of contingent consideration       (0.8) $ 8.2
business combination, contingent consideration arrangement, payment   $ 0.0   0.0 $ (9.9)
Balance at March 31, 2016   $ 15.9   $ 15.9  
Forward Contract Indexed to Issuer's Equity, Classification   40      
ExecuPharm Inc. [Member]          
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Payments to Acquire Businesses, Gross 148.9        
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $ 20.0        
Fair Value Inputs, Discount Rate       1.00%  
Fair Value, Measurement Inputs, Disclosure [Text Block]       15 months  
Contingent Consideration [Roll Forward]          
Change in fair value of contingent consideration       $ 2.5  
Forward Contracts [Member]          
Contingent Consideration [Roll Forward]          
Balance at June 30, 2015     0.0 0.0  
Additions of contingent consideration due to Health Advances acquisition       40.0  
Change in fair value of contingent consideration       (20.7)  
Balance at March 31, 2016   $ 0.0   $ 0.0  
FY2017StockRepurchasePlan [Member] [Domain] [Domain]          
Contingent Consideration [Roll Forward]          
Accelerated Share Repurchase Program, Adjustment   $ 19.3 $ 19.7